Subsequently, the majority of the studies uncovered that MAGI2-AS3 may regulate their target genes (such as CCDC19, and SMG1) by functioning as a competing endogenous RNA for miRNAs (such as miR-15b-5p and miR-374a/b-5p) in cancers (39, 40). The gene discussed is MAGI2; the disease is cancer.